Biogen Announces Pursual of FDA Approval for Aducanumab
Biogen and its Japanese partner Eisai announced Oct. 22nd an unexpected reversal—pharmaceutical giant Biogen said it will pursue US Food […]
Biogen and its Japanese partner Eisai announced Oct. 22nd an unexpected reversal—pharmaceutical giant Biogen said it will pursue US Food […]
AbbVie terminated a clinical trial of its intravenously administered antibody, designed to slow the progression of Progressive Supranuclear Palsy (PSP), […]
The Alzheimer’s Association gave $6 million to the University of California, Davis, to fund its participation in the U.S. POINTER […]
After a review of the clinical data, sponsors Amgen and Novartis have concluded that the potential benefit for participants in […]
Kerwin Research Center and Memory Care focuses on the care, evaluation and treatment of memory loss and dementia due to […]
Weak microglia may constitute a link between two hallmarks of Alzheimer’s disease—clumps of amyloid- β protein and tangles of tau […]
A Lund University Study confirms that a simple blood test can reveal whether there is accelerating nerve cell damage in […]
University of Chicago researchers engaged in preclinical research have redeemed amyloid precursor protein (APP), a contributor to Alzheimer’s disease, as […]
University of South Florida-Led preclinical study helps uncovered promising therapeutic target for Alzheimer’s disease. Researchers have known that Apolipoprotein E […]
Janice Wood of PsychCentral reports that new research has uncovered a link between high LDL cholesterol levels and early-onset Alzheimer’s […]